Search Results

. hASH1 expression is closely correlated with endocrine phenotype and differentiation extent in pulmonary neuroendocrine tumors . Mod Pathol 2004 ; 17 : 222 – 229 . 5. Darnell RB Posner JB . Paraneoplastic syndromes involving the nervous

Paraneoplastic syndromes occur in 10% to 15% of malignancies and are most often associated with carcinomas of the lung, breast, and ovary. Cancer-associated retinopathy (CAR) is a heterogenous group of paraneoplastic autoimmune disorders resulting from

well-recognized paraneoplastic manifestation of thymoma. This report discusses a patient with recurrent thymoma complicated by myasthenia gravis (MG), PRCA, and AAMT several years after the initial diagnosis; both PRCA and AAMT responded successfully to

of SCLC, which results in the development of symptomatic disease between annual scans, thereby limiting the potential effect on mortality. 20 Many neurologic and endocrine paraneoplastic syndromes are associated with SCLC. 21 - 23 Neurologic

: Miller RD, ed. Miller's Anesthesia, 6th ed. Oxford : Churchill-Livingstone ; 2005 . 58. Jameson JL Johnson BE . Paraneoplastic syndromes: endocrine/hematologic . In: Kasper DL, Braunwald E, Fauci A, et al. eds. Harrison's Principles

for Neuroendocrine and Adrenal Tumors, at NCCN.org ). 21 , 22 Many neurologic and endocrine paraneoplastic syndromes are associated with SCLC. 23 – 25 Neurologic syndromes include Lambert-Eaton myasthenic syndrome, encephalomyelitis, and sensory

Darnell RB Posner JB . Paraneoplastic syndromes involving the nervous system . N Engl J Med 2003 ; 349 : 1543 – 1554 . 82 Berger T Malayeri R Doppelbauer A . Neurological monitoring of neurotoxicity induced by paclitaxel

TC was attributed to a paraneoplastic process secondary to metastatic adenocarcinoma of the lung, and he experienced complete resolution of LV dysfunction with supportive care. 19 Recently, a case was reported of TC that occurred in a patient with

of the aggressiveness of SCLC, which results in the development of symptomatic disease between annual scans, thereby limiting the potential effect on mortality. 22 Many neurologic and endocrine paraneoplastic syndromes are associated with SCLC. 23

that of insulin itself, and randomized trials do not confirm the increased risk associated with insulin therapy. 16 On the other hand, PDA-associated DM has been postulated to be a paraneoplastic phenomenon caused by a tumor-secreted diabetogenic